On 22 August 2019, the Commission received a notification from the competent German authority stating that it deemed the prescription medicinal product BioBag (ATC code D03AX and pharmaceutical form ‘fly larvae’) not to be at risk of falsification in accordance with the criteria set out in Article 54a(2), point (b), of Directive 2001/83/EC, and that the medicinal product should therefore be exempted from the requirement to bear safety features.
Recital 5, Regulation (EU) 2021/1686
In forcesince 7 Jul 2021